RCM plus dermoscopy improves detection of LM/LMM, malignant lesions

một ngày trước
RCM plus dermoscopy improves detection of LM/LMM, malignant lesions

The integration of reflectance confocal microscopy (RCM) to dermoscopic triage of equivocal lesions results in improved sensitivity detection of lentigo maligna (LM) or LM melanoma (LMM) and enhanced specificity for benign lesions compared with dermoscopy alone, a study has shown. This strategy helps reduce overtreatment and missed malignancies.

A total of 2,006 lesions from 801 patients (mean age 66.2 percent) were included in the analysis. Following RCM‒dermoscopy integration, 236 of 2,006 (11.8 percent) lesions were deemed malignant (226 biopsied/excised; 10 noninvasively treated: eight basal cell carcinoma [BCC] and two LM).

Some 26 lesions changed at follow-up and were then removed, of which four were malignant (0.4 percent; three LM and one BCC). Histology of 252 lesions confirmed 114 malignancies, of which 62 were LM/LMM and 52 BCC or squamous cell carcinoma (SCC).

Notably, dermoscopy detected 54.8 percent of LM/LMM and 90.4 percent of BCC/SCC, while RCM diagnosed 91.9 percent of LM/LMM and 94.2 percent of BCC/SCC.

“Although a small residual risk of missed malignancy persists, the combined approach offers a highly safe, noninvasive pathway for managing equivocal lesions in cosmetically sensitive areas,” said the investigators, who conducted this prospective multicentre study of equivocal flat macules in the head and neck.

Lesions suspicious or discordant underwent biopsy or excision, and double-negative lesions were followed for at least 1 year. Histopathology served as the reference standard.

The study was limited by verification and selection biases and follow-up losses.

J Am Acad Dermatol 2026;95:1362-1369